NCT04884685View on ClinicalTrials.gov

Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

June 20, 2022

Conditions
COVID-19
Interventions
BIOLOGICAL

SARS-CoV-2 Inactivated Vaccine

600SU inactivated virus in 0·5 mL of aluminium hydroxide solution per injection

BIOLOGICAL

Placebo

aluminium hydroxide solution only

Trial Locations (1)

051230

Zanhuang county Center for Disease Control and Prevention, Shijiazhuang

All Listed Sponsors
lead

Sinovac Life Sciences Co., Ltd.

INDUSTRY